| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2025 | Oct 23, 2025 | Summit Therapeutics Inc. | CEO | Buy | 85.0 | +14,274,277 | 2.41% | ✗ | $500K |
| Sep 10, 2025 | Sep 11, 2025 | Summit Therapeutics Inc. | CEO | Buy | 66.3 | +338,394 | 0.06% | ✗ | $6M |
| Mar 27, 2024 | Mar 27, 2024 | Summit Therapeutics Inc. | CEO | Buy | 67.5 | +110,321 | 0.43% | ✗ | $411.1K |
| Dec 11, 2023 | Dec 13, 2023 | Summit Therapeutics Inc. | CEO | Buy | 78.8 | +5,000 | 1.02% | ✗ | $10.4K |
| Mar 8, 2023 | Mar 13, 2023 | Summit Therapeutics Inc. | CEO | Buy | 100.0 | +23,527,044 | 215.24% | ✗ | $24.7M |
| Mar 8, 2023 | Mar 8, 2023 | Summit Therapeutics Inc. | CEO | Buy | 100.0 | +23,527,044 | 215.24% | ✗ | $24.7M |
| Aug 16, 2022 | Aug 18, 2022 | Summit Therapeutics Inc. | CEO | Buy | 100.0 | +5,809,132 | 122.35% | ✗ | $5.6M |
| May 12, 2021 | May 14, 2021 | Summit Therapeutics Inc. | COO | Buy | 95.0 | +389,077 | 8.93% | ✗ | $2M |
| Jun 23, 2020 | Jun 25, 2020 | PULSE BIOSCIENCES, INC. | Director | Buy | 61.3 | +1,193 | 0.24% | ✗ | $12.8K |
| Jun 17, 2020 | Jun 19, 2020 | PULSE BIOSCIENCES, INC. | Director | Buy | 82.5 | +7,950 | 1.62% | ✗ | $55.7K |
| Feb 13, 2017 | Mar 28, 2018 | PULSE BIOSCIENCES, INC. | Director | Buy | 97.5 | +23,700 | 136.99% | ✗ | $338.9K |
| Dec 13, 2017 | Dec 15, 2017 | PULSE BIOSCIENCES, INC. | Director | Buy | 61.3 | +1,100 | 0.26% | ✗ | $26.4K |
| Dec 11, 2017 | Dec 13, 2017 | PULSE BIOSCIENCES, INC. | Director | Buy | 72.5 | +4,000 | 0.95% | ✗ | $92.3K |
| Sep 14, 2017 | Sep 18, 2017 | PULSE BIOSCIENCES, INC. | Director | Buy | 92.5 | +29,775 | 7.57% | ✗ | $397.7K |
| Aug 2, 2017 | Aug 4, 2017 | PULSE BIOSCIENCES, INC. | Director | Buy | 92.5 | +28,790 | 7.90% | ✗ | $689.8K |
| May 11, 2017 | May 11, 2017 | PULSE BIOSCIENCES, INC. | Director | Buy | 100.0 | +53,760 | 17.31% | ✗ | $1.1M |
| Mar 20, 2017 | Mar 20, 2017 | PULSE BIOSCIENCES, INC. | Director | Buy | 92.5 | +18,240 | 6.24% | ✗ | $425.7K |
| Feb 15, 2017 | Feb 22, 2017 | PULSE BIOSCIENCES, INC. | Director | Buy | 87.5 | +13,000 | 4.65% | ✗ | $155.6K |